---

---

tags : N::A    symbols : ALNY   

save search

---

Liver Disease Therapeutics Competitive Landscape and Market Forecasts to 2028
Published: 2024-02-12 (Crawled : 20:00) - prnewswire.com
ALPMY | News | $9.46 500K |

Manufacturing

| -13.68% | O: 0.37% H: 0.74% C: 0.28%
BMY | $47.895 0.12% 4.6M |

Health Technology

| -2.99% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $165.54 0.78% 2.2M |

Health Technology

| -5.28% | O: 0.8% H: 0.0% C: 0.0%
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| -0.19% | O: -0.06% H: 0.0% C: 0.0%
GILD | $66.2 -1.09% 3.3M |

Health Technology

| -10.1% | O: 0.32% H: 0.11% C: -1.55%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -13.36% | O: -2.63% H: 0.98% C: -1.75%
liver disease therapeutics market

---

Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Published: 2024-02-02 (Crawled : 12:00) - globenewswire.com
TSVT | $4.85 -4.15% 330K |

| -2.5% | O: -1.16% H: 9.94% C: 2.34%
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| -4.85% | O: -0.93% H: 0.0% C: 0.0%
REGN | $900.22 -0.11% 150K |

Health Technology

| -5.91% | O: 1.4% H: 0.28% C: -2.68%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -16.12% | O: -1.23% H: 1.0% C: 0.17%
year financial results

---

Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | News | $745.46 -0.71% 940K |

Health Technology

| 19.0% | O: -0.51% H: 0.37% C: 0.32%
MDGL M | $221.84 -2.85% 150K |

Health Technology

| -2.08% | O: 1.29% H: 0.35% C: -3.04%
HEPA | $2.1 -1.41% 25K |

Health Technology

| 1.91% | O: -0.48% H: 7.69% C: 1.44%
ALT | $7.04 1.7M |

Commercial Services

| -25.1% | O: -0.8% H: 6.02% C: 0.6%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -20.23% | O: 0.46% H: 3.04% C: 2.67%
ETNB | News | $9.035 -1.37% 220K |

Health Technology

| -13.37% | O: 1.19% H: 0.63% C: -0.72%
liver disease companies key growth market

---

Regeneron to Highlight Scientific Advancements Across Diversified Pipeline in Difficult-to-Treat Blood Cancers and Disorders at ASH
Published: 2023-11-03 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| 0.22% | O: -1.79% H: 0.0% C: 0.0%
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| -1.91% | O: -3.04% H: 0.0% C: 0.0%
REGN | $900.22 -0.11% 150K |

Health Technology

| 10.06% | O: 2.37% H: 0.12% C: -2.54%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -9.17% | O: 1.95% H: 2.7% C: 1.62%
disorders pipeline blood

---

Regeneron Reports Third Quarter 2023 Financial and Operating Results
Published: 2023-11-02 (Crawled : 11:00) - globenewswire.com
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| 1.03% | O: 3.0% H: 0.0% C: 0.0%
REGN | $900.22 -0.11% 150K |

Health Technology

| 13.89% | O: 0.08% H: 4.96% C: 3.4%
NTLA | $21.61 0.51% 250K |

Health Technology

| -15.69% | O: 2.35% H: 1.63% C: 1.46%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -6.55% | O: 3.4% H: 0.57% C: -0.5%
financial results

---

Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
Published: 2023-10-11 (Crawled : 12:00) - globenewswire.com
VIR | $8.18 -0.85% 270K |

Health Technology

| -7.09% | O: -0.9% H: 2.27% C: 0.68%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -13.21% | O: -1.16% H: 1.43% C: 0.43%
meeting hepatitis liver presentation

---

RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Published: 2023-09-15 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 1.4K |

Health Technology

| -14.44% | O: 1.53% H: 0.0% C: 0.0%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 10.49% | O: 0.79% H: 0.0% C: 0.0%
ALPMY | News | $9.46 500K |

Manufacturing

| -37.69% | O: 3.0% H: 0.0% C: -3.43%
PFE A | $25.325 -0.37% 15M |

Health Technology

| -25.56% | O: -0.26% H: 1.04% C: 0.03%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -8.59% | O: 1.51% H: 0.26% C: -0.72%
SRPT | $117.05 -0.71% 150K |

Health Technology

| -1.53% | O: -0.27% H: 0.54% C: -0.84%
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| -15.47% | O: 0.82% H: 0.0% C: 0.0%
MRNA | News S | $101.87 -1.52% 710K |

Health Technology

| -8.31% | O: 0.16% H: 2.0% C: 1.42%
IONS | $41.14 0.56% 210K |

Health Technology

| -6.26% | O: -0.57% H: 0.35% C: -1.11%
BNTX | $86.015 -0.45% 280K |

Health Technology

| -24.14% | O: 0.17% H: 0.48% C: -0.82%
ARWR | $22.57 0.18% 630K |

Health Technology

| -22.5% | O: 0.16% H: 0.46% C: -5.46%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -24.0% | O: -0.74% H: 2.42% C: -3.47%
therapeutics market

---

Advancements in Diagnosis and Treatment Fuel Rising Prevalence of Thalassemia, Driving Market to 2028
Published: 2023-08-25 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 510 |

Health Technology

| 18.3% | O: 2.25% H: 0.0% C: 0.0%
NVS | News | $92.61 -0.51% 430K |

Health Technology

| -7.7% | O: 0.67% H: 0.37% C: 0.26%
GSK | $39.2 -1.01% 1.2M |

Health Technology

| 14.88% | O: 0.67% H: 0.45% C: 0.2%
SGMO | $0.5115 -0.87% 620K |

Health Technology

| -42.86% | O: -3.19% H: 0.0% C: 0.0%
IONS | $41.14 0.56% 210K |

Health Technology

| 2.76% | O: 0.0% H: 1.68% C: 1.28%
EDIT | $5.57 -0.71% 620K |

Health Technology

| -33.6% | O: 0.11% H: 1.25% C: -0.57%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -21.44% | O: -0.12% H: 2.12% C: 1.45%
treatment market

---

Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Published: 2023-08-03 (Crawled : 20:00) - globenewswire.com
JNJ | News | $144.54 -0.16% 4.9M |

Health Technology

| -14.82% | O: 0.19% H: 0.0% C: 0.0%
XNCR | $19.0 -0.37% 120K |

Health Technology

| -18.33% | O: 7.75% H: 4.65% C: -3.9%
VIR | $8.18 -0.85% 270K |

Health Technology

| -40.94% | O: -0.36% H: 2.51% C: -2.16%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -22.82% | O: -0.42% H: 0.0% C: -1.97%
update financial results

---

Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera
Published: 2023-08-03 (Crawled : 11:00) - globenewswire.com
ALNY | $144.675 -0.44% 130K |

Health Technology

| -20.53% | O: -1.35% H: 5.58% C: 4.38%
AGIO | $29.59 1.93% 170K |

Health Technology

| 11.41% | O: -2.4% H: 5.98% C: 2.81%
license treatment potential agreement

---

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight
Published: 2023-07-12 (Crawled : 21:00) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M |

Health Technology

| -19.53% | O: 1.7% H: 0.01% C: -0.32%
LLY | News | $745.46 -0.71% 940K |

Health Technology

| 70.4% | O: -0.08% H: 0.46% C: -1.26%
MDGL M | $221.84 -2.85% 150K |

Health Technology

| 3.56% | O: 0.41% H: 3.34% C: 1.43%
LPCN | $5.47 2.82% 15K |

Health Technology

| 20.36% | O: 0.11% H: 2.15% C: 1.02%
GALT | $3.43 1.48% 90K |

Health Technology

| 116.67% | O: 0.64% H: 7.01% C: 5.1%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -27.33% | O: 0.69% H: 1.02% C: 0.29%
AKRO | $20.47 -5.23% 320K |

Health Technology

| -51.63% | O: 0.78% H: 1.1% C: -0.15%
cirrhosis liver growth market

---

Recently-Appointed Independent Directors of Alkermes Issue Open Letter to Shareholders
Published: 2023-06-26 (Crawled : 11:00) - investor.alkermes.com
JNJ | News | $144.54 -0.16% 4.9M |

Health Technology

| -12.52% | O: -0.3% H: 0.0% C: -0.82%
UTHR | $239.5 1.78% 200K |

Health Technology

| 5.82% | O: 0.04% H: 0.04% C: -0.76%
RARE | $44.16 0.11% 220K |

Health Technology

| -12.13% | O: -0.44% H: 0.0% C: -2.72%
SRPT | $117.05 -0.71% 150K |

Health Technology

| 3.33% | O: -0.08% H: 0.44% C: -5.02%
SAGE | News | $13.46 7.08% 610K |

Health Technology

| -74.74% | O: -0.44% H: 1.31% C: -3.25%
PTCT | News | $25.02 -0.56% 170K |

Health Technology

| -39.34% | O: -0.24% H: 0.48% C: -2.37%
NBIX M | $132.24 -0.74% 110K |

Health Technology

| 38.22% | O: 0.15% H: 0.81% C: -0.46%
JAZZ | News | $108.225 1.05% 200K |

Health Technology

| -14.22% | O: -0.22% H: 1.13% C: 0.39%
IRWD | $7.59 -0.78% 580K |

Health Technology

| -30.01% | O: -0.09% H: 0.27% C: -2.56%
IONS | $41.14 0.56% 210K |

Health Technology

| 3.2% | O: 0.05% H: 0.16% C: -1.41%
INCY | $52.59 -0.25% 880K |

Health Technology

| -15.58% | O: 0.06% H: 0.91% C: 0.72%
EXEL | $22.67 -0.88% 1.1M |

Health Technology

| 15.94% | O: -0.15% H: 0.0% C: -1.87%
BPMC | $90.33 2.21% 410K |

Health Technology

| 34.9% | O: 0.0% H: 0.08% C: -1.72%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -23.86% | O: -0.26% H: 0.62% C: -0.44%
ALKS | News | $23.75 -1.08% 800K |

Health Technology

| -27.65% | O: 1.11% H: 0.0% C: -3.11%
ACAD | News | $17.04 -0.87% 250K |

Health Technology

| -29.78% | O: -0.24% H: 0.82% C: -2.41%

---

Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 as Therapies for Chronic Hepatitis B and Hepatitis D
Published: 2023-06-24 (Crawled : 12:20) - globenewswire.com
ALNY | $144.675 -0.44% 130K |

Health Technology

| Email alert Add to watchlist
VIR | $8.18 -0.85% 270K |

Health Technology

| Email alert Add to watchlist
vir-2218 hepatitis vir-3434 potential

---

Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors
Published: 2023-06-13 (Crawled : 11:00) - investor.alkermes.com
ENDPQ | $0.0006 620K |

n/a

| -92.45% | O: -47.17% H: 110.71% C: 96.43%
IRM | $74.65 -0.66% 450K |

Finance

| 33.32% | O: -0.18% H: 0.94% C: 0.2%
LLY | News | $745.46 -0.71% 940K |

Health Technology

| 68.59% | O: -0.37% H: 0.84% C: 0.46%
AMRX | $5.345 -2.11% 310K |

Health Technology

| 116.27% | O: 0.4% H: 8.7% C: 1.98%
ZLAB | $14.175 3.32% 320K |

Health Technology

| -50.34% | O: 0.94% H: 0.0% C: -0.93%
VRTX | $393.46 0.09% 350K |

Health Technology

| 15.41% | O: 0.08% H: 1.04% C: 0.36%
UTHR | $239.5 1.78% 200K |

Health Technology

| 3.25% | O: -0.65% H: 2.13% C: 1.37%
RARE | $44.16 0.11% 220K |

Health Technology

| -14.18% | O: 0.72% H: 2.22% C: 0.5%
SRPT | $117.05 -0.71% 150K |

Health Technology

| -9.36% | O: 0.55% H: 2.23% C: -0.71%
SAGE | News | $13.46 7.08% 610K |

Health Technology

| -78.2% | O: 0.07% H: 2.89% C: 1.85%
PTCT | News | $25.02 -0.56% 170K |

Health Technology

| -41.96% | O: -0.3% H: 2.48% C: 1.97%
PRTA 4 | $20.68 -1.52% 180K |

Health Technology

| -71.24% | O: 0.29% H: 5.34% C: 4.38%
NBIX M | $132.24 -0.74% 110K |

Health Technology

| 42.51% | O: 0.05% H: 2.35% C: 2.29%
MDXG | $6.185 -2.29% 190K |

Health Technology

| 7.29% | O: 0.85% H: 1.34% C: -0.17%
LPTX | $2.905 -3.17% 66K |

Health Technology

| -54.87% | O: 0.0% H: 9.63% C: 9.63%
JAZZ | News | $108.225 1.05% 200K |

Health Technology

| -14.74% | O: -0.02% H: 1.93% C: 1.16%
IRWD | $7.59 -0.78% 580K |

Health Technology

| -33.01% | O: 0.0% H: 0.35% C: -3.42%
IONS | $41.14 0.56% 210K |

Health Technology

| -1.73% | O: 0.17% H: 1.25% C: 0.46%
INFI | $0.016 12.5% 1.1M |

Health Technology

| -91.05% | O: 0.0% H: 0.0% C: -5.76%
INCY | $52.59 -0.25% 880K |

Health Technology

| -15.1% | O: -0.48% H: 1.44% C: 0.24%
IDXX | $478.37 0.03% 220K |

Health Technology

| 3.86% | O: 0.31% H: 1.9% C: 1.42%
EXEL | $22.67 -0.88% 1.1M |

Health Technology

| 20.61% | O: 0.05% H: 0.89% C: 0.52%
CYCN | $3.2182 150 |

Health Technology

| -26.9% | O: 6.44% H: 0.41% C: -1.94%
BPMC | $90.33 2.21% 410K |

Health Technology

| 49.38% | O: 0.62% H: 2.47% C: 0.53%
AXLA | $4.58 -56.33% 42K |

Health Technology

| 1377.42% | O: -1.06% H: 6.94% C: -2.15%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -24.01% | O: 0.07% H: 2.64% C: 2.23%
ALKS | News | $23.75 -1.08% 800K |

Health Technology

| -22.74% | O: 0.19% H: 1.58% C: 0.64%
ACAD | News | $17.04 -0.87% 250K |

Health Technology

| -30.07% | O: 0.12% H: 1.83% C: 1.58%
IBIO | $1.75 -7.41% 140K |

Health Technology

| 159.44% | O: 16.68% H: 3.53% C: -11.59%

---

Alkermes Publishes Investor Presentation Detailing Company's Transformation and Value Creation
Published: 2023-06-08 (Crawled : 11:00) - investor.alkermes.com
JNJ | News | $144.54 -0.16% 4.9M |

Health Technology

| -8.67% | O: -0.01% H: 1.21% C: 1.11%
UTHR | $239.5 1.78% 200K |

Health Technology

| 6.64% | O: 0.37% H: 2.61% C: 2.27%
RARE | $44.16 0.11% 220K |

Health Technology

| -14.88% | O: -0.33% H: 1.43% C: -0.14%
SRPT | $117.05 -0.71% 150K |

Health Technology

| -7.83% | O: -0.4% H: 1.32% C: -1.16%
SAGE | News | $13.46 7.08% 610K |

Health Technology

| -77.76% | O: -0.34% H: 1.12% C: 0.64%
PTCT | News | $25.02 -0.56% 170K |

Health Technology

| -42.27% | O: -0.48% H: 1.54% C: -1.87%
NBIX M | $132.24 -0.74% 110K |

Health Technology

| 42.95% | O: 0.0% H: 1.27% C: 0.89%
JAZZ | News | $108.225 1.05% 200K |

Health Technology

| -16.67% | O: -0.4% H: 1.52% C: -0.33%
IRWD | $7.59 -0.78% 580K |

Health Technology

| -33.54% | O: 0.52% H: 0.69% C: 0.26%
IONS | $41.14 0.56% 210K |

Health Technology

| 0.89% | O: -0.12% H: 3.43% C: 2.84%
INCY | $52.59 -0.25% 880K |

Health Technology

| -14.12% | O: 0.18% H: 0.41% C: 0.02%
EXEL | $22.67 -0.88% 1.1M |

Health Technology

| 19.49% | O: 0.0% H: 1.71% C: 0.42%
BPMC | $90.33 2.21% 410K |

Health Technology

| 43.41% | O: -0.9% H: 1.07% C: -4.84%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -22.85% | O: 0.03% H: 1.32% C: 0.11%
ALKS | News | $23.75 -1.08% 800K |

Health Technology

| -22.32% | O: 0.32% H: 3.63% C: 1.25%
ACAD | News | $17.04 -0.87% 250K |

Health Technology

| -30.13% | O: -1.1% H: 4.89% C: 3.0%
presentation

---

Vir Biotechnology Announces Multiple Abstracts Highlighting New Hepatitis B and D Data Accepted for Presentation at EASL™ Congress 2023
Published: 2023-06-07 (Crawled : 06:00) - globenewswire.com
VIR | $8.18 -0.85% 270K |

Health Technology

| -68.32% | O: -0.38% H: 1.85% C: -0.15%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -23.96% | O: -0.46% H: 0.17% C: -0.99%
hepatitis presentation

---

Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value
Published: 2023-05-25 (Crawled : 21:00) - investor.alkermes.com
JNJ | News | $144.54 -0.16% 4.9M |

Health Technology

| -6.24% | O: 0.18% H: 0.38% C: -0.22%
UTHR | $239.5 1.78% 200K |

Health Technology

| 10.92% | O: 0.0% H: 0.84% C: -2.27%
RARE | $44.16 0.11% 220K |

Health Technology

| -11.64% | O: 0.3% H: 0.45% C: -0.48%
SRPT | $117.05 -0.71% 150K |

Health Technology

| -8.51% | O: -0.01% H: 0.64% C: -1.58%
SAGE | News | $13.46 7.08% 610K |

Health Technology

| -74.43% | O: 0.43% H: 2.19% C: 1.76%
PTCT | News | $25.02 -0.56% 170K |

Health Technology

| -42.11% | O: -0.48% H: 1.78% C: -1.36%
NBIX M | $132.24 -0.74% 110K |

Health Technology

| 44.53% | O: 0.28% H: 1.44% C: -1.32%
JAZZ | News | $108.225 1.05% 200K |

Health Technology

| -16.03% | O: -0.32% H: 0.51% C: -0.98%
IRWD | $7.59 -0.78% 580K |

Health Technology

| -28.7% | O: -0.19% H: 2.05% C: 0.93%
IONS | $41.14 0.56% 210K |

Health Technology

| 4.44% | O: 0.08% H: 4.23% C: 3.93%
INCY | $52.59 -0.25% 880K |

Health Technology

| -16.14% | O: 0.0% H: 0.21% C: -0.46%
EXEL | $22.67 -0.88% 1.1M |

Health Technology

| 20.99% | O: -0.05% H: 1.47% C: 0.58%
BPMC | $90.33 2.21% 410K |

Health Technology

| 58.6% | O: 0.04% H: 6.92% C: 6.35%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -21.12% | O: 0.27% H: 1.27% C: 0.94%
ALKS | News | $23.75 -1.08% 800K |

Health Technology

| -17.9% | O: 0.03% H: 1.02% C: -0.24%
ACAD | News | $17.04 -0.87% 250K |

Health Technology

| -29.61% | O: -0.25% H: 1.68% C: 1.6%
business

---

Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI
Published: 2023-05-11 (Crawled : 12:20) - globenewswire.com
VIR | $8.18 -0.85% 270K |

Health Technology

| -66.24% | O: -0.74% H: 0.52% C: -0.04%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -30.45% | O: 0.09% H: 0.0% C: -2.4%
vir-2218 hepatitis virus trial

---

Regeneron Reports First Quarter 2023 Financial and Operating Results
Published: 2023-05-04 (Crawled : 10:00) - globenewswire.com
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| -14.26% | O: 1.56% H: 0.0% C: 0.0%
REGN | $900.22 -0.11% 150K |

Health Technology

| 12.2% | O: -3.44% H: 0.13% C: -2.79%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -26.46% | O: 1.11% H: 2.3% C: 1.82%
financial results

---

Nonalcoholic Steatohepatitis Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Madrigal, Intercept, AstraZeneca, Gilead, Pfizer, Alnylam, Eli Lilly and Company, Novo Nordisk
Published: 2023-04-24 (Crawled : 15:00) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M |

Health Technology

| -27.87% | O: -1.02% H: 0.31% C: -0.24%
LLY | News | $745.46 -0.71% 940K |

Health Technology

| 94.88% | O: 0.0% H: 0.47% C: -0.49%
VKTX | News | $64.84 -2.45% 1.5M |

Health Technology

| 213.39% | O: 0.99% H: 2.87% C: -0.42%
SNY | News | $45.445 -1.44% 2.6M |

Health Technology

| -18.32% | O: -0.22% H: 0.0% C: 0.0%
MTCR | $0.5814 -5.14% 84K |

Health Technology

| 4.95% | O: 0.63% H: 1.35% C: 0.45%
MDGL M | $221.84 -2.85% 150K |

Health Technology

| -24.76% | O: -0.33% H: 1.28% C: 1.12%
LPCN | $5.47 2.82% 15K |

Health Technology

| 6.44% | O: -2.31% H: 7.94% C: 1.01%
IONS | $41.14 0.56% 210K |

Health Technology

| 10.78% | O: 0.38% H: 0.0% C: -3.64%
HEPA | $2.1 -1.41% 25K |

Health Technology

| -85.2% | O: 0.04% H: 1.48% C: -3.31%
GALT | $3.43 1.48% 90K |

Health Technology

| 76.04% | O: 0.0% H: 1.04% C: -4.17%
CWBR | $0.9003 360 |

Health Technology

| -57.86% | O: -3.68% H: 1.1% C: -1.63%
ALT | $7.04 1.7M |

Commercial Services

| 29.88% | O: -0.69% H: 0.87% C: -4.0%
ALNY | $144.675 -0.44% 130K |

Health Technology

| -29.89% | O: -0.08% H: 0.18% C: -2.07%
ETNB | News | $9.035 -1.37% 220K |

Health Technology

| -43.32% | O: -0.06% H: 0.0% C: -5.88%
companies active rapid market

---

Gainers vs Losers

73%

27%

Top 10 Gainers

AGBA | $1.05 162.5% 100M |

Finance

ISPC | $0.4621 116.95% 15M |

Professional, Scientific, and T...

INVO | $1.515 99.34% 4.3M |

Health Technology

BPTH | $5.62 73.46% 75M |

Health Technology

TIRX | $0.8231 69.78% 54M |

SINT | $0.0519 39.14% 350M |

Health Technology

XPON | $2.63 36.27% 8.4M |

VTNR S | $1.26 28.68% 9.1M |

Industrial Services

SWVL | $9.64 27.35% 200K |

n/a

DFLI A | $0.7726 25.52% 4.3M |

---

Your saved searches

---